µþ°ùø»å°ì°ù³Ü³¾³¾±ð Forside Spero Therapeutics Spero Therapeutics Spero has a pipeline of novel treatments for multi-drug resistant (MDR) bacterial infections. Two programs are in clinical phase I Â鶹Éç BioCapital ±õ²Ô±¹±ð²õ³Ù±ð°ù¾±²Ô²µ²õÃ¥°ù 2015 IPO in 2017 – SPRO (Nasdaq) Lokation Boston, Massachusetts, USA
